Giorgio Inghirami

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Patient Reported

Inflammatory Response

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

André Figueiredo Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Singh, Ayana Morales, Robert A DeSimone, Grant B Ellsworth, Rosemary Soave, Shashi N Kapadia, Kohta Saito, Christopher D Brown, JingMei Hsu, Christopher Kyriakides, Steven Chui, Luca Vincenzo Cappelli, Maria Teresa Cacciapuoti, Wayne Tam, Lorenzo Galluzzi, Paul D Simonson, Olivier Elemento, Mirella Salvatore, Giorgio Inghirami
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv : the preprint server for health sciences (2020)
Alexandra Gomez-Arteaga, Elizabeth M Margolskee, Mike Tzuhen Wei, Koen van Besien, Giorgio Inghirami, Steven M Horwitz
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. Leukemia & lymphoma 60 (7) (2019)
Irene Della Starza, Lucia Anna De Novi, Alessandra Santoro, Domenico Salemi, Wayne Tam, Marzia Cavalli, Lucia Menale, Roberta Soscia, Valerio Apicella, Caterina Ilari, Antonella Vitale, Anna Maria Testi, Giorgio Inghirami, Sabina Chiaretti, Caterina Ilari, Anna Guarini
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia. Leukemia & lymphoma 60 (11) (2019)